Toll Free: 1-888-928-9744

Vivaldi Biosciences Inc. - Product Pipeline Review - 2014

Published: May, 2014 | Pages: 27 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Vivaldi Biosciences Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Vivaldi Biosciences Inc. - Product Pipeline Review - 2014', provides an overview of the Vivaldi Biosciences Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vivaldi Biosciences Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Vivaldi Biosciences Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Vivaldi Biosciences Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Vivaldi Biosciences Inc.'s pipeline products

Reasons to buy

- Evaluate Vivaldi Biosciences Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Vivaldi Biosciences Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Vivaldi Biosciences Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Vivaldi Biosciences Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vivaldi Biosciences Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Vivaldi Biosciences Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Vivaldi Biosciences Inc. Snapshot 5
Vivaldi Biosciences Inc. Overview 5
Key Information 5
Key Facts 5
Vivaldi Biosciences Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Vivaldi Biosciences Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Vivaldi Biosciences Inc. - Pipeline Products Glance 10
Vivaldi Biosciences Inc. - Late Stage Pipeline Products 10
Phase III Products/Combination Treatment Modalities 10
Vivaldi Biosciences Inc. - Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Vivaldi Biosciences Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Vivaldi Biosciences Inc. - Drug Profiles 14
influenza vaccine, split virion, inactivated 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
GHB-16L2 Vaccine 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
H1N1 Pandemic Influenza Vaccine 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
GHB-04L1 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Int-NS1 LAIV for Seasonal Influenza 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Vaccines for Influenza A H7N9 Infections 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Vivaldi Biosciences Inc. - Pipeline Analysis 20
Vivaldi Biosciences Inc. - Pipeline Products by Route of Administration 20
Vivaldi Biosciences Inc. - Pipeline Products by Molecule Type 21
Vivaldi Biosciences Inc. - Recent Pipeline Updates 22
Vivaldi Biosciences Inc. - Dormant Projects 24
Vivaldi Biosciences Inc. - Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 27
Disclaimer 27
List of Tables
Vivaldi Biosciences Inc., Key Information 5
Vivaldi Biosciences Inc., Key Facts 5
Vivaldi Biosciences Inc. - Pipeline by Indication, 2014 7
Vivaldi Biosciences Inc. - Pipeline by Stage of Development, 2014 8
Vivaldi Biosciences Inc. - Monotherapy Products in Pipeline, 2014 9
Vivaldi Biosciences Inc. - Phase III, 2014 10
Vivaldi Biosciences Inc. - Phase I, 2014 11
Vivaldi Biosciences Inc. - Preclinical, 2014 12
Vivaldi Biosciences Inc. - Discovery, 2014 13
Vivaldi Biosciences Inc. - Pipeline by Route of Administration, 2014 20
Vivaldi Biosciences Inc. - Pipeline by Molecule Type, 2014 21
Vivaldi Biosciences Inc. - Recent Pipeline Updates, 2014 22
Vivaldi Biosciences Inc. - Dormant Developmental Projects,2014 24 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify